General Info
Location: 27 Fitzroy Square, London, England, United Kingdom, W1T 6ES
Country: United Kingdom of Great Britain and Northern Ireland
Industries: venture capital & private equity
Investment Regions: EU
Investment Stages: pre-seed, seed
Website: http://www.adventls.com
vc
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: active
AI Reasoning: Advent Life Sciences has documented investments in 2025 (e.g., co-leading Cyted Health’s $44M Series B on 2 Sep 2025 and other portfolio/news items in 2025 such as Glycomine, Glycomine Series C on 16 Apr 2025). The most recent known investment (Cyted Health 2 Sep 2025) is within 6 to 3 months prior to the reference date, which places the investor in the corresponding activity band.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
Kaasim …
General Partner
Satish …
General Partner
Shahzad …
General Partner
Dominic …
General Partner
…
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Advent Life Sciences
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI